Cardiomyopathy Causes
Cardiomyopathy Causes
Cardiomyopathy has more than one road leading to it, and the roads are not distinguished by how the heart looks. A dilated, weak heart can follow an inherited variant, a viral infection, years of heavy drinking or a course of chemotherapy, and the echocardiogram cannot tell them apart. What separates them is what the answer changes: whether there is a therapy aimed at the cause, and above all whether relatives are at risk. This page sets out the three roads, the mimic that is most often filed under another name, what it means when no cause is found, and the difference between what starts the disease and what drives it forward.
Three roads to the same abnormal muscle
Causes arrive on three roads. The first is inherited: a variant in one of the proteins that build the muscle, or in the structures that anchor it. The second is acquired: injury from an infection, from alcohol, from chemotherapy or radiotherapy, from a pregnancy, or from a rhythm that has been running too fast for too long. The third is infiltrative or metabolic: something is deposited inside the muscle, or something the muscle depends on is missing. Many patients turn out to have more than one of these — a family tendency, plus an injury that tipped it — and a proportion have none identified at all, even after a complete work-up.
Two rules organise the search. The first is that the same final picture can come from several roads at once, and the appearance of the heart does not say which: a dilated and weak heart can follow a variant in a contractile protein, a virus, years of heavy drinking or a course of chemotherapy, and the echocardiogram shows the same dilated chamber in each case. What differs is what the answer does — whether a therapy exists that is aimed at the cause, and above all whether relatives share the risk. The second rule is that a cause is worth pursuing even when it will not change the patient's own medicine, because it changes the family's plan, and because a cause that can be removed is worth removing.
This page describes each road in turn. What makes a stable heart become an unstable one is a related but separate question — the drivers rather than the causes — and it is dealt with at the end of the page and, in practical terms, on the prevention page.
When the cause is written in the family
The muscle is built from proteins: the filaments that slide past one another to shorten the muscle cell, the structures that anchor them, the channels that move calcium and sodium in and out, and the enzymes that supply the energy. A change in the gene for any of them can produce muscle that assembles or works abnormally, and many of these changes pass from parent to child in a dominant pattern — which means an affected parent has an even chance of passing it on to each child, and a family can carry the risk for two or three generations without anyone being diagnosed until an event forces the question.
Different genes produce recognisably different behaviours, and that is why finding the gene is more than bookkeeping. Some variants make the muscle thick with a strong tendency towards rhythm problems while the wall is still barely thickened — the pattern behind the phrase "electrically loud, structurally quiet", and the reason a normal echocardiogram in a carrier does not end that person's surveillance. Others produce a dilated and weak heart. Others replace the right ventricle with scar and fat. Others interfere with the heart's ability to relax, or with the conduction system, sometimes before any structural change can be seen at all.
Two things follow for families. The first is that a gene result converts screening from a guess into an instruction: rather than testing everybody indefinitely, the family tests for the specific variant, and the relatives who carry it remain in surveillance while those who do not can be discharged. The second is that the absence of a gene result does not remove the family risk. Where no variant is found — or where testing has not been done — relatives are screened by examination and imaging rather than by a test, on an interval suggested by the type of disease and the family history. The family screening programme is set out on the prevention page of this guide.
Acquired causes: what injures the muscle
The acquired road is the one where something outside the muscle attacks it, or where the heart is worked beyond what it can sustain. Each of these has a different consequence, and two of them can be removed.
| Cause | How it injures the muscle | What changes because of it |
|---|---|---|
| Myocarditis (viral or immune) | Inflammation damages muscle cells directly and provokes an immune response that can continue to act after the original trigger has gone | Recognising it changes the treatment: some patients need immunosuppression rather than heart-failure medication alone, and the muscle can stabilise or improve |
| Alcohol | A direct toxin to the muscle cell; heavy intake sustained over years is one of the most identifiable causes of a dilated, weak heart | It is one of the few causes that can be removed entirely, and the muscle may then stabilise over months rather than continue to deteriorate |
| Chemotherapy and chest radiotherapy | Certain drugs injure the muscle cell directly; radiation damages the small vessels and the pericardium, sometimes years after the treatment finished | It changes surveillance: patients with a treatment history are followed differently and investigated earlier than their symptoms alone would prompt |
| Pregnancy (peripartum cardiomyopathy) | Heart failure developing towards the end of pregnancy or in the months afterwards, through mechanisms that are still being worked out | It changes the plan for any future pregnancy, which is why these patients are followed closely rather than discharged once they feel better |
| A sustained fast rhythm | A rhythm that has been running fast for weeks or months can weaken the pump on its own, without any structural disease to begin with | The clearest example of a cause treated by treating something else: control the rhythm, and the muscle may recover much of what it lost |
| Long-standing high blood pressure or valve disease | The muscle thickens or dilates in response to a load it cannot escape, sometimes over decades and without symptoms in between | Where the load explains everything, the condition is named for its cause rather than called cardiomyopathy — and treating the pressure or the valve treats the muscle |
The last row sits at the border of the definition, and the border is worth understanding rather than glossing over. A heart thickened or dilated by untreated blood pressure, or by a valve that has been leaking for years, is affected in exactly the same way as one with a cardiomyopathy — but where the loading condition accounts for all of it, the condition is named for its cause and the treatment is aimed there first. That is not a technicality: it means the pressure and the valve deserve aggressive treatment, because the muscle responds to it.
Cardiac amyloidosis: the cause most often filed under another name
One acquired cause deserves its own section, because it is the one most often filed under another name. In cardiac amyloidosis, a protein that has folded incorrectly is deposited between the muscle cells as fibrils. The wall becomes thick and stiff, the heart refuses to fill, and the picture looks like hypertrophic or restrictive disease — while the treatment is entirely different. Two forms matter in practice: transthyretin amyloidosis, which may be inherited or may occur with age, and light-chain (AL) amyloidosis, which arises from a plasma-cell disorder and moves quickly if it is not treated.
The reason it is missed is that each individual finding looks like ordinary ageing. Breathlessness attributed to being older; a thick wall on the echocardiogram attributed to blood pressure; an ECG that looks unexpectedly ordinary for the thickness of the wall — which is a clue rather than reassurance, because amyloid infiltrates the muscle without generating the electrical voltage that muscle does; carpal tunnel surgery some years earlier; numbness or tingling in the feet; a blood pressure that falls on standing, or that makes heart-failure medication unusually hard to tolerate. It is the combination, not any single item, that should raise the flag.
What changes when it is named is the treatment, and the change is substantial. Both forms have therapy directed at the protein itself rather than at the pump, and the light-chain form needs urgent treatment by a haematology team because it is a different disease running on a different clock. The family implications differ too: hereditary transthyretin amyloidosis is inherited, while the age-related form and the light-chain form are not. Because therapies aimed at the protein exist, the cost of missing the diagnosis is not academic — which is why the tests that identify it belong inside the work-up rather than after it.
When no cause is found
In a proportion of patients the work-up does not identify a cause. This is an honest outcome rather than a failure of the process: it usually means the cause lies below the resolution of current testing — an inherited variant that has not yet been characterised, an injury that happened long ago, or a mechanism that is not yet understood.
Calling the condition idiopathic does not mean that nothing can be done. The management is the same as for a cardiomyopathy with a named cause: treat the symptoms, protect against dangerous rhythms, monitor the function and the rhythm over time, and address the drivers that make a stable heart unstable. The one place where the plan differs is the family. Without a variant to test for, relatives are screened by examination and imaging rather than by a gene test, on an interval suggested by the type of disease and by what the family history shows.
The search can also be reopened, and sometimes it should be. A patient who was idiopathic five years ago may not be idiopathic today: imaging techniques improve, and the appearance of the heart itself changes with time in ways that make a cause visible where it previously was not. A second look at old images, or a repeat scan years later, occasionally produces the answer that the first round could not reach — which is one reason the records are worth keeping in a form the family can hand over.
Cause and driver: what makes it worse
There is a difference between what started the disease and what drives it forward, and the second list is the more actionable one. Whatever began the process — a variant, a virus, an exposure — the muscle usually goes on to remodel, and several things determine how fast that happens.
- The hormonal response itself. A pump that is not meeting demand triggers a sustained hormonal response that raises pressure and retains salt — useful for a week, harmful across years, because it is the process that keeps reshaping the muscle. This is precisely the process the heart-failure medication exists to block.
- Continuing exposure to a toxin. Alcohol is the clearest example: the muscle does not get a chance to stabilise while the exposure continues, however effective the rest of the treatment is.
- Load. Blood pressure, a leaking valve, untreated sleep apnoea and excess weight all make an abnormal muscle work harder than it needs to, and a load that a healthy heart shrugs off can be decisive in a stiff one.
- Rhythm. A fast rhythm accelerates the decline and can create weakness on its own, while the loss of coordination between the two ventricles makes the same muscle pump less effectively.
- Deconditioning. Rest that goes beyond what is actually needed removes capacity that then has to be rebuilt, and every symptom becomes limiting at a lower level of activity than before.
Two things follow from separating causes from drivers. The first is that a patient can act on this list even when nobody can change the diagnosis — and that is exactly why it is the list used to build the prevention plan rather than a commentary on it. The second is that these drivers are not equally important in every type: dehydration that would be trivial in a healthy person can worsen obstruction in hypertrophic disease, and a blood pressure that a normal heart tolerates easily can be poorly tolerated by a stiff one. Which driver applies to which type, and what to do about each, is set out on the prevention page.